Firing of FDA probationary staff creates widespread uncertainty
Regulatory NewsFerdous Al-Faruque
Biologics/ biosimilars/ vaccinesGovernment/legislationLeadershipMedical DevicesPharmaceuticalsRegulatory Intelligence/PolicyUnited StatesUS Food and Drug Administration (FDA)